Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 40 entries
Sorted by: Best Match Show Resources per page
Evolving role of immunotherapy in the treatment of refractory warts.

Indian dermatology online journal

Thappa DM, Chiramel MJ.
PMID: 27730031
Indian Dermatol Online J. 2016 Sep-Oct;7(5):364-370. doi: 10.4103/2229-5178.190487.

Cutaneous and genital warts are common dermatological conditions caused by the human papilloma virus (HPV). Although it is a benign condition, it causes disfigurement, has a tendency to koebnerize, and can be transmitted to others. This makes adequate and...

Cite
Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refractory warts. Indian Dermatol Online J. 2016;7(5):364-370doi: 10.4103/2229-5178.190487.
Thappa, D. M., & Chiramel, M. J. (2016). Evolving role of immunotherapy in the treatment of refractory warts. Indian dermatology online journal, 7(5), 364-370. https://doi.org/10.4103/2229-5178.190487
Thappa, Devinder M, and Chiramel, Minu J. "Evolving role of immunotherapy in the treatment of refractory warts." Indian dermatology online journal vol. 7,5 (2016): 364-370. doi: https://doi.org/10.4103/2229-5178.190487
Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refractory warts. Indian Dermatol Online J. 2016 Sep-Oct;7(5):364-370. doi: 10.4103/2229-5178.190487. PMID: 27730031; PMCID: PMC5038096.
Copy Download .nbib Format: NLM
Percutaneous gastrostomy placement by intervention radiology: Techniques and outcome.

The Indian journal of radiology & imaging

Karthikumar B, Keshava SN, Moses V, Chiramel GK, Ahmed M, Mammen S.
PMID: 30050247
Indian J Radiol Imaging. 2018 Apr-Jun;28(2):225-231. doi: 10.4103/ijri.IJRI_393_17.

BACKGROUND: Interventional radiology (IR) has played an important role in the technical evolution of gastrostomy, from the first surgical, endoscopical to percutaneous interventional procedures.AIM: This study is done to assess the technical feasibility and outcome of IR-guided percutaneous gastrostomy...

Cite
Karthikumar B, Keshava SN, Moses V, et al. Percutaneous gastrostomy placement by intervention radiology: Techniques and outcome. Indian J Radiol Imaging. 2018;28(2):225-231doi: 10.4103/ijri.IJRI_393_17.
Karthikumar, B., Keshava, S. N., Moses, V., Chiramel, G. K., Ahmed, M., & Mammen, S. (2018). Percutaneous gastrostomy placement by intervention radiology: Techniques and outcome. The Indian journal of radiology & imaging, 28(2), 225-231. https://doi.org/10.4103/ijri.IJRI_393_17
Karthikumar, Balasubramanian, et al. "Percutaneous gastrostomy placement by intervention radiology: Techniques and outcome." The Indian journal of radiology & imaging vol. 28,2 (2018): 225-231. doi: https://doi.org/10.4103/ijri.IJRI_393_17
Karthikumar B, Keshava SN, Moses V, Chiramel GK, Ahmed M, Mammen S. Percutaneous gastrostomy placement by intervention radiology: Techniques and outcome. Indian J Radiol Imaging. 2018 Apr-Jun;28(2):225-231. doi: 10.4103/ijri.IJRI_393_17. PMID: 30050247; PMCID: PMC6038225.
Copy Download .nbib Format: NLM
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.

bioRxiv : the preprint server for biology

Shi G, Chiramel AI, Majdoul S, Lai KK, Das S, Beare PA, Andresson T, Best SM, Compton AA.
PMID: 33880473
bioRxiv. 2021 Apr 16; doi: 10.1101/2021.04.15.440067.

Infection by SARS-CoV-2 generally causes mild symptoms but can lead to severe disease and death in certain populations, including the immunocompromised. Drug repurposing efforts are underway to identify compounds that interfere with SARS-CoV-2 replication or the immunopathology it can...

Cite
Shi G, Chiramel AI, Majdoul S, et al. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2021;doi: 10.1101/2021.04.15.440067.
Shi, G., Chiramel, A. I., Majdoul, S., Lai, K. K., Das, S., Beare, P. A., Andresson, T., Best, S. M., & Compton, A. A. (2021). Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.04.15.440067
Shi, Guoli, et al. "Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.04.15.440067
Shi G, Chiramel AI, Majdoul S, Lai KK, Das S, Beare PA, Andresson T, Best SM, Compton AA. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2021 Apr 16; doi: 10.1101/2021.04.15.440067. PMID: 33880473; PMCID: PMC8057238.
Copy Download .nbib Format: NLM
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.

bioRxiv : the preprint server for biology

Shi G, Chiramel AI, Majdoul S, Lai KK, Das S, Beare PA, Andresson T, Best SM, Compton AA.
PMID: 33880473
bioRxiv. 2021 Apr 16; doi: 10.1101/2021.04.15.440067.

Infection by SARS-CoV-2 generally causes mild symptoms but can lead to severe disease and death in certain populations, including the immunocompromised. Drug repurposing efforts are underway to identify compounds that interfere with SARS-CoV-2 replication or the immunopathology it can...

Cite
Shi G, Chiramel AI, Majdoul S, et al. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2021;doi: 10.1101/2021.04.15.440067.
Shi, G., Chiramel, A. I., Majdoul, S., Lai, K. K., Das, S., Beare, P. A., Andresson, T., Best, S. M., & Compton, A. A. (2021). Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.04.15.440067
Shi, Guoli, et al. "Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.04.15.440067
Shi G, Chiramel AI, Majdoul S, Lai KK, Das S, Beare PA, Andresson T, Best SM, Compton AA. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2021 Apr 16; doi: 10.1101/2021.04.15.440067. PMID: 33880473; PMCID: PMC8057238.
Copy Download .nbib Format: NLM
Giant cerebriform intradermal nevus in a young girl.

Indian dermatology online journal

Sahni K, Singh S, Bhari N, Chiramel MJ, Ali F.
PMID: 27730054
Indian Dermatol Online J. 2016 Sep-Oct;7(5):443-444. doi: 10.4103/2229-5178.190513.

No abstract available.

Cite
Sahni K, Singh S, Bhari N, et al. Giant cerebriform intradermal nevus in a young girl. Indian Dermatol Online J. 2016;7(5):443-444doi: 10.4103/2229-5178.190513.
Sahni, K., Singh, S., Bhari, N., Chiramel, M. J., & Ali, F. (2016). Giant cerebriform intradermal nevus in a young girl. Indian dermatology online journal, 7(5), 443-444. https://doi.org/10.4103/2229-5178.190513
Sahni, Kanika, et al. "Giant cerebriform intradermal nevus in a young girl." Indian dermatology online journal vol. 7,5 (2016): 443-444. doi: https://doi.org/10.4103/2229-5178.190513
Sahni K, Singh S, Bhari N, Chiramel MJ, Ali F. Giant cerebriform intradermal nevus in a young girl. Indian Dermatol Online J. 2016 Sep-Oct;7(5):443-444. doi: 10.4103/2229-5178.190513. PMID: 27730054; PMCID: PMC5038119.
Copy Download .nbib Format: NLM
Radiofrequency ablation of osteoid osteoma in common and technically challenging locations in pediatric population.

The Indian journal of radiology & imaging

Garge S, Keshava SN, Moses V, Chiramel GK, Ahmed M, Mammen S, Madhuri V.
PMID: 28515594
Indian J Radiol Imaging. 2017 Jan-Mar;27(1):88-91. doi: 10.4103/0971-3026.202955.

CONTEXT: Percutaneous radiofrequency ablation (RFA) of osteoid osteoma has a high technical and clinical success rate. However, there is limited data on its use in the pediatric population, especially in technically challenging locations.OBJECTIVE: To assess the safety and efficacy...

Cite
Garge S, Keshava SN, Moses V, et al. Radiofrequency ablation of osteoid osteoma in common and technically challenging locations in pediatric population. Indian J Radiol Imaging. 2017;27(1):88-91doi: 10.4103/0971-3026.202955.
Garge, S., Keshava, S. N., Moses, V., Chiramel, G. K., Ahmed, M., Mammen, S., & Madhuri, V. (2017). Radiofrequency ablation of osteoid osteoma in common and technically challenging locations in pediatric population. The Indian journal of radiology & imaging, 27(1), 88-91. https://doi.org/10.4103/0971-3026.202955
Garge, Shaileshkumar, et al. "Radiofrequency ablation of osteoid osteoma in common and technically challenging locations in pediatric population." The Indian journal of radiology & imaging vol. 27,1 (2017): 88-91. doi: https://doi.org/10.4103/0971-3026.202955
Garge S, Keshava SN, Moses V, Chiramel GK, Ahmed M, Mammen S, Madhuri V. Radiofrequency ablation of osteoid osteoma in common and technically challenging locations in pediatric population. Indian J Radiol Imaging. 2017 Jan-Mar;27(1):88-91. doi: 10.4103/0971-3026.202955. PMID: 28515594; PMCID: PMC5385785.
Copy Download .nbib Format: NLM
Nasoalveolar moulding for children with unilateral cleft lip and palate.

Journal of maxillofacial and oral surgery

Chammanam SG, Biswas PP, Kalliath R, Chiramel S.
PMID: 24821996
J Maxillofac Oral Surg. 2014 Jun;13(2):87-91. doi: 10.1007/s12663-013-0490-y. Epub 2013 Mar 16.

INTRODUCTION: Cleft lip and palate represents the most frequently occurring congenital deformity second only to club foot deformity in our country. Wide alveolar clefts if not preceded by pre surgical orthodontic adjuncts like nasoalveolar moulding, may affect the final...

Cite
Chammanam SG, Biswas PP, Kalliath R, et al. Nasoalveolar moulding for children with unilateral cleft lip and palate. J Maxillofac Oral Surg. 2013;13(2):87-91doi: 10.1007/s12663-013-0490-y.
Chammanam, S. G., Biswas, P. P., Kalliath, R., & Chiramel, S. (2014). Nasoalveolar moulding for children with unilateral cleft lip and palate. Journal of maxillofacial and oral surgery, 13(2), 87-91. https://doi.org/10.1007/s12663-013-0490-y
Chammanam, Shaju George, et al. "Nasoalveolar moulding for children with unilateral cleft lip and palate." Journal of maxillofacial and oral surgery vol. 13,2 (2014): 87-91. doi: https://doi.org/10.1007/s12663-013-0490-y
Chammanam SG, Biswas PP, Kalliath R, Chiramel S. Nasoalveolar moulding for children with unilateral cleft lip and palate. J Maxillofac Oral Surg. 2014 Jun;13(2):87-91. doi: 10.1007/s12663-013-0490-y. Epub 2013 Mar 16. PMID: 24821996; PMCID: PMC4016396.
Copy Download .nbib Format: NLM
Clinical outcomes of endovascularly managed iatrogenic renal hemorrhages.

The Indian journal of radiology & imaging

Chiramel GK, Keshava SN, Moses V, Kekre N, Tamilarasi V, Devasia A.
PMID: 26752819
Indian J Radiol Imaging. 2015 Oct-Dec;25(4):380-90. doi: 10.4103/0971-3026.169454.

OBJECTIVE: To evaluate the effectiveness of endovascular management in iatrogenic renal injuries with regard to clinical status on follow-up and requirements for repeat angiography and embolization.MATERIALS AND METHODS: This retrospective study included patients who were referred for endovascular management...

Cite
Chiramel GK, Keshava SN, Moses V, et al. Clinical outcomes of endovascularly managed iatrogenic renal hemorrhages. Indian J Radiol Imaging. 2015;25(4):380-90doi: 10.4103/0971-3026.169454.
Chiramel, G. K., Keshava, S. N., Moses, V., Kekre, N., Tamilarasi, V., & Devasia, A. (2015). Clinical outcomes of endovascularly managed iatrogenic renal hemorrhages. The Indian journal of radiology & imaging, 25(4), 380-90. https://doi.org/10.4103/0971-3026.169454
Chiramel, George Koshy, et al. "Clinical outcomes of endovascularly managed iatrogenic renal hemorrhages." The Indian journal of radiology & imaging vol. 25,4 (2015): 380-90. doi: https://doi.org/10.4103/0971-3026.169454
Chiramel GK, Keshava SN, Moses V, Kekre N, Tamilarasi V, Devasia A. Clinical outcomes of endovascularly managed iatrogenic renal hemorrhages. Indian J Radiol Imaging. 2015 Oct-Dec;25(4):380-90. doi: 10.4103/0971-3026.169454. PMID: 26752819; PMCID: PMC4693387.
Copy Download .nbib Format: NLM
Recommendations for Pediatric Dermatology Practice during COVID-19 Pandemic.

Indian dermatology online journal

Gulati R, Katakam BK, Ranugha PSS, Gupta M, Rao TN, Panda M, Munisamy M, Chiramel MJ, Puri N, Gupta S, Behera B, Dabas G.
PMID: 34976882
Indian Dermatol Online J. 2021 Nov 25;12:S66-S70. doi: 10.4103/idoj.IDOJ_814_20. eCollection 2021 Nov.

The current scenario of the coronavirus disease (COVID-19) pandemic has resulted in a huge disease burden worldwide affecting people across all age groups. Although children get infected by coronavirus, they are less commonly affected. Only 2% of cases are...

Cite
Gulati R, Katakam BK, Ranugha PSS, et al. Recommendations for Pediatric Dermatology Practice during COVID-19 Pandemic. Indian Dermatol Online J. 2021;12:S66-S70doi: 10.4103/idoj.IDOJ_814_20.
Gulati, R., Katakam, B. K., Ranugha, P. S. S., Gupta, M., Rao, T. N., Panda, M., Munisamy, M., Chiramel, M. J., Puri, N., Gupta, S., Behera, B., & Dabas, G. (2021). Recommendations for Pediatric Dermatology Practice during COVID-19 Pandemic. Indian dermatology online journal, 12S66-S70. https://doi.org/10.4103/idoj.IDOJ_814_20
Gulati, Ram, et al. "Recommendations for Pediatric Dermatology Practice during COVID-19 Pandemic." Indian dermatology online journal vol. 12 (2021): S66-S70. doi: https://doi.org/10.4103/idoj.IDOJ_814_20
Gulati R, Katakam BK, Ranugha PSS, Gupta M, Rao TN, Panda M, Munisamy M, Chiramel MJ, Puri N, Gupta S, Behera B, Dabas G. Recommendations for Pediatric Dermatology Practice during COVID-19 Pandemic. Indian Dermatol Online J. 2021 Nov 25;12:S66-S70. doi: 10.4103/idoj.IDOJ_814_20. eCollection 2021 Nov. PMID: 34976882; PMCID: PMC8664170.
Copy Download .nbib Format: NLM
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.

bioRxiv : the preprint server for biology

Shi G, Chiramel AI, Majdoul S, Lai KK, Das S, Beare PA, Andresson T, Best SM, Compton AA.
PMID: 33880473
bioRxiv. 2021 Apr 16; doi: 10.1101/2021.04.15.440067.

Infection by SARS-CoV-2 generally causes mild symptoms but can lead to severe disease and death in certain populations, including the immunocompromised. Drug repurposing efforts are underway to identify compounds that interfere with SARS-CoV-2 replication or the immunopathology it can...

Cite
Shi G, Chiramel AI, Majdoul S, et al. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2021;doi: 10.1101/2021.04.15.440067.
Shi, G., Chiramel, A. I., Majdoul, S., Lai, K. K., Das, S., Beare, P. A., Andresson, T., Best, S. M., & Compton, A. A. (2021). Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.04.15.440067
Shi, Guoli, et al. "Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.04.15.440067
Shi G, Chiramel AI, Majdoul S, Lai KK, Das S, Beare PA, Andresson T, Best SM, Compton AA. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2021 Apr 16; doi: 10.1101/2021.04.15.440067. PMID: 33880473; PMCID: PMC8057238.
Copy Download .nbib Format: NLM
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.

bioRxiv : the preprint server for biology

Shi G, Chiramel AI, Majdoul S, Lai KK, Dempsey T, Kenney A, Zani A, Eddy A, Zhang L, Das S, Beare PA, Andresson T, Kar S, Yount JS, Best SM, Compton AA.
PMID: 33880473
bioRxiv. 2022 Jan 06; doi: 10.1101/2021.04.15.440067.

SARS-CoV-2 infection in immunocompromised individuals is associated with prolonged virus shedding and the evolution of viral variants. Rapamycin and its analogs (rapalogs, including everolimus, temsirolimus, and ridaforolimus) are FDA-approved as mTOR inhibitors in clinical settings such as cancer and...

Cite
Shi G, Chiramel AI, Majdoul S, et al. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2022;doi: 10.1101/2021.04.15.440067.
Shi, G., Chiramel, A. I., Majdoul, S., Lai, K. K., Dempsey, T., Kenney, A., Zani, A., Eddy, A., Zhang, L., Das, S., Beare, P. A., Andresson, T., Kar, S., Yount, J. S., Best, S. M., & Compton, A. A. (2022). Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.04.15.440067
Shi, Guoli, et al. "Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2." bioRxiv : the preprint server for biology vol. (2022). doi: https://doi.org/10.1101/2021.04.15.440067
Shi G, Chiramel AI, Majdoul S, Lai KK, Dempsey T, Kenney A, Zani A, Eddy A, Zhang L, Das S, Beare PA, Andresson T, Kar S, Yount JS, Best SM, Compton AA. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2022 Jan 06; doi: 10.1101/2021.04.15.440067. PMID: 33880473; PMCID: PMC8057238.
Copy Download .nbib Format: NLM
Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2.

bioRxiv : the preprint server for biology

Shi G, Chiramel AI, Majdoul S, Lai KK, Das S, Beare PA, Andresson T, Best SM, Compton AA.
PMID: 33880473
bioRxiv. 2021 Apr 16; doi: 10.1101/2021.04.15.440067.

Infection by SARS-CoV-2 generally causes mild symptoms but can lead to severe disease and death in certain populations, including the immunocompromised. Drug repurposing efforts are underway to identify compounds that interfere with SARS-CoV-2 replication or the immunopathology it can...

Cite
Shi G, Chiramel AI, Majdoul S, et al. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2021;doi: 10.1101/2021.04.15.440067.
Shi, G., Chiramel, A. I., Majdoul, S., Lai, K. K., Das, S., Beare, P. A., Andresson, T., Best, S. M., & Compton, A. A. (2021). Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.04.15.440067
Shi, Guoli, et al. "Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.04.15.440067
Shi G, Chiramel AI, Majdoul S, Lai KK, Das S, Beare PA, Andresson T, Best SM, Compton AA. Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2. bioRxiv. 2021 Apr 16; doi: 10.1101/2021.04.15.440067. PMID: 33880473; PMCID: PMC8057238.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 40 entries